South Africa suspends Oxford-AstraZeneca Covid-19 vaccine
– – South Africa has suspended the use of the Oxford-AstraZeneca coronavirus vaccination. Tests conducted by the country have shown that the vaccine developed by drug-maker AstraZeneca and the University of Oxford offered only limited protection against mild and moderate disease caused by the 501Y.V2 coronavirus variant first identified in South Africa. The SA government had planned to roll the Oxford/AstraZeneca…
Read More
